Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...

Argent BioPharma and AusCann Group have joined forces with a new strategic agreement to advance cannabinoid-based pharmaceutical development by sharing proprietary data and regulatory expertise.

Q1 2025 saw a broad crypto market pullback, divergence between price and sentiment, and a return to fundamentals, according ...

Taking place at a critical time of regulatory change in Canada and beyond, the 3rd Annual Methane Mitigation Canada Summit is back, offering the ideal blend of cutting-edge technical case studies, ...

Menarini Biotech, a group company of Italy’s Menarini, has entered into a strategic collaboration with ERBC, a leading ...

2 There are, however, many challenges that innovators need to overcome from a development, regulatory, and CMC (chemistry, manufacturing, and controls) perspective. As a still-novel class of ...

The Eastern Caribbean countries which operate Citizenship by Investment Programmes (CBI) will gather in Antigua later this ...

Because of its long-standing existence in the crypto market, many investors first consider ripple (XRP) among altcoins with ...

ISELIN, NJ, USA I April 08, 2025 I Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for ...